Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucagon RTU for Exercise-Induced Hypoglycemia in T1D
NCT03841526Phase 2Completed
- Sponsor
- Xeris Biopharma Holdings, Inc.
- Start
- Aug 2019
- Primary completion
- Apr 2020
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of G-Pen, sponsored by Xeris Biopharma Holdings, Inc.. Started Aug 2019; status: completed.
02
Drugs
G-Pen
Beyond the preview
Go deeper on NCT03841526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03841526.